MP Biomedicals Asia Pacific Pte Ltd – FDA 483, Mar 21, 2025
MP Biomedicals Asia Pacific Pte Ltd, an IVD manufacturer in Singapore, was cited for inadequate environmental control procedures, including a failure to establish criteria for corrective actions when environmental limits were exceeded, resulting in out-of-specification microbial counts. The inspection also found that the firm lacked approved purchasing data and effective purchase agreements for critical suppliers. These issues indicate a lack of adequate controls over manufacturing environments and supplier management.
ID · 7728d5e1-451a-449b-8177-438c81e12a5c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.